| Literature DB >> 30559475 |
Xiao Yu1, Wen Li2, Ying Ma1, Kyoko Tossell1, Julia J Harris1,3, Edward C Harding1, Wei Ba1, Giulia Miracca1, Dan Wang2, Long Li2, Juan Guo2, Ming Chen4, Yuqi Li1, Raquel Yustos1, Alexei L Vyssotski5, Denis Burdakov3, Qianzi Yang2, Hailong Dong6, Nicholas P Franks7,8,9, William Wisden10,11,12.
Abstract
We screened for novel circuits in the mouse brain that promote wakefulness. Chemogenetic activation experiments and electroencephalogram recordings pointed to glutamatergic/nitrergic (NOS1) and GABAergic neurons in the ventral tegmental area (VTA). Activating glutamatergic/NOS1 neurons, which were wake- and rapid eye movement (REM) sleep-active, produced wakefulness through projections to the nucleus accumbens and the lateral hypothalamus. Lesioning the glutamate cells impaired the consolidation of wakefulness. By contrast, activation of GABAergic VTA neurons elicited long-lasting non-rapid-eye-movement-like sleep resembling sedation. Lesioning these neurons produced an increase in wakefulness that persisted for at least 4 months. Surprisingly, these VTA GABAergic neurons were wake- and REM sleep-active. We suggest that GABAergic VTA neurons may limit wakefulness by inhibiting the arousal-promoting VTA glutamatergic and/or dopaminergic neurons and through projections to the lateral hypothalamus. Thus, in addition to its contribution to goal- and reward-directed behaviors, the VTA has a role in regulating sleep and wakefulness.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30559475 PMCID: PMC6390936 DOI: 10.1038/s41593-018-0288-9
Source DB: PubMed Journal: Nat Neurosci ISSN: 1097-6256 Impact factor: 24.884